Advanced search
Publication Cover
Current Medical Research and Opinion Volume 34, 2018 - Issue 1
Submit an article Journal homepage
639
Views
8
CrossRef citations to date
0
Altmetric
Cardiovascular

Cost-effectiveness analysis of dabigatran versus rivaroxaban for stroke prevention in patients with non-valvular atrial fibrillation using real-world evidence in elderly US Medicare beneficiaries

Siyang PengEvidera, Bethesda, MD, USA;
,
Kristen A. DegerEvidera, Bethesda, MD, USA;
,
Anastasia UstyugovaBoehringer Ingelheim GmbH, Ingelheim am Rhein, Germany;
,
Pranav GandhiBoehringer-Ingelheim Pharmaceuticals Inc.,Ridgefield, CT, USA
,
Nan QiaoEvidera, Bethesda, MD, USA;
,
Cheng WangBoehringer-Ingelheim Pharmaceuticals Inc.,Ridgefield, CT, USA
&
Anuraag R. KansalEvidera, Bethesda, MD, USA; Correspondence[email protected]
 show all
Pages 55-63 | Received 06 Jun 2017, Accepted 24 Aug 2017, Published online: 26 Sep 2017

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.